Using PET-CT to Target and Validate Low-frequency TMS as Treatment for Tinnitus
Tinnitus
About this trial
This is an interventional treatment trial for Tinnitus focused on measuring Tinnitus, TMS, Transcranial Magnetic Stimulation
Eligibility Criteria
Inclusion Criteria: right-handed subjects 19-65 years of age debilitating unilaterial or bilateral tinnitus Experiencing the presence of phantom auditory preception for >6 months Tinnitus Handicap Questionnaire score of >30 Exclusion Criteria: significant neurological disease acoustic neuromas or glomus tumors active Meniere's disease profound hearing loss non English speaking personal or family history of epilepsy personal history of head injury, aneurysm, stroke, previous cranial neurosurgery, neurological or psychiatric disorders, metal implants in the head or neck, a pacemaker, pregnancy, migraines, medications that lower seizure threshold and are contraindicated individuals who have been taking certain medications claustrophobia patients who do not exhibit significant cortical asymmetries on PET
Sites / Locations
- University of Arkansas for Medical Sciences
Arms of the Study
Arm 1
Sham Comparator
Active versus Sham Treatment
Subjects randomly assigned to active and sham TMS separated by one week interval.